Q3 2024 |
27 |
$345M |
+$31.1M |
-$43.3M |
-$12.1M |
PLD, EQIX, WELL, CCI, SPG
|
13F-HR |
10/29/2024, 09:30 AM |
Q2 2024 |
27 |
$313M |
+$29.4M |
-$19.2M |
+$10.2M |
PLD, EQIX, WELL, CCI, NSA
|
13F-HR |
8/7/2024, 09:48 AM |
Q1 2024 |
25 |
$316M |
+$23M |
-$16.9M |
+$6.12M |
EQIX, PLD, WELL, CCI, NSA
|
13F-HR |
4/23/2024, 08:26 AM |
Q4 2023 |
27 |
$318M |
+$11.3M |
-$18.1M |
-$6.82M |
PLD, EQIX, CCI, WELL, NSA
|
13F-HR |
1/29/2024, 10:27 AM |
Q3 2023 |
27 |
$276M |
+$34.3M |
-$33.8M |
+$459K |
PLD, EQIX, WELL, CCI, SPG
|
13F-HR |
11/7/2023, 08:53 AM |
Q2 2023 |
27 |
$300M |
+$20.7M |
-$20.3M |
+$381K |
PLD, EQIX, WELL, SBAC, SPG
|
13F-HR |
8/9/2023, 09:04 AM |
Q1 2023 |
25 |
$302M |
+$45.8M |
-$35M |
+$10.8M |
PLD, EQIX, WELL, SBAC, SPG
|
13F-HR |
4/27/2023, 09:27 AM |
Q4 2022 |
26 |
$285M |
+$27.7M |
-$11.9M |
+$15.8M |
PLD, SBAC, EQIX, WELL, SPG
|
13F-HR |
2/10/2023, 08:56 AM |
Q3 2022 |
26 |
$253M |
+$17.8M |
-$38.5M |
-$20.7M |
PLD, SBAC, EQIX, WELL, SPG
|
13F-HR |
11/14/2022, 09:28 AM |
Q2 2022 |
29 |
$309M |
+$50.1M |
-$58.3M |
-$8.17M |
PLD, SBAC, EQIX, NSA, ARE
|
13F-HR |
8/1/2022, 11:22 AM |
Q1 2022 |
33 |
$382M |
+$79.6M |
-$86.3M |
-$6.69M |
SBAC, PLD, EQIX, CUBE, NSA
|
13F-HR |
5/5/2022, 10:54 AM |
Q4 2021 |
34 |
$420M |
+$71.5M |
-$86.6M |
-$15.1M |
SBAC, NSA, PECO, EQIX, REXR
|
13F-HR |
2/3/2022, 01:17 PM |
Q3 2021 |
38 |
$375M |
+$50.7M |
-$48.2M |
+$2.55M |
SBAC, EQIX, PLD, CCI, REXR
|
13F-HR |
11/2/2021, 01:37 PM |
Q2 2021 |
33 |
$376M |
+$42.8M |
-$47.7M |
-$4.95M |
EQIX, SBAC, PLD, CCI, AMH
|
13F-HR |
7/27/2021, 01:13 PM |
Q1 2021 |
29 |
$344M |
+$26.6M |
-$27.8M |
-$1.16M |
EQIX, SBAC, CCI, PLD, SUI
|
Restatement |
5/17/2021, 06:07 PM |
Q4 2020 |
28 |
$337M |
$0 |
$0 |
|
EQIX, SBAC, CCI, PLD, ARE
|
13F-HR |
2/10/2021, 09:49 AM |